Why is Concord Biotech falling/rising?

As of 27-Jun, Concord Biotech Ltd's stock price is rising, currently at Rs 1,823.40, reflecting an increase of Rs 27.65 or 1.54%. Today's performance shows that the stock has outperformed its sector by 0.66%, reaching an intraday high of Rs 1,836.95, which is a 2.29% increase. Despite a recent decline in delivery volume by 69.7% against the 5-day average, the stock remains liquid enough for trading. Over the past month, it has shown a strong return of 19.10%, although it has underperformed in the past week with a decline of 0.90%. The company has demonstrated strong long-term fundamentals, with a healthy operating profit growth rate of 26.51% and a solid average return on equity of 20.62%. Additionally, institutional investors have increased their stake, indicating growing confidence in the company's prospects.
Broader market context reveals that while Concord Biotech has generated a return of 16.93% over the past year, this is significantly higher than the broader market's return of 4.10%. However, in the short term, the stock's performance has lagged behind the benchmark, as it has declined by 0.90% in the past week compared to the Sensex's increase of 2.00%. This contrast highlights the stock's recent volatility despite its strong long-term outlook and positive institutional interest, suggesting that while the company has solid fundamentals, market conditions may be affecting its short-term performance.